Devices › Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes
Device brand name · Implantable lead
Ingevity +: medical device reports filed with FDA
3,053 reports name it, 2022–2026. Manufacturer given most often on reports: Boston Scientific. Product code NVN.
- 3,053
- device reports naming the brand
- 0% of all MAUDE reports · about 680 a year
- 2,281
- reports, 12 months to August 2026
- 749 in the 12 months before
- 35.8%
- classified as malfunction
- 41.6% across the product code
- 0.6%
- classified as death, as reported
- 17 reports · not verified by FDA
3,053 medical device reports received by FDA name the brand "Ingevity +" (implantable lead); the manufacturer given most often on reports is Boston Scientific; received from January 2022 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
2,281 reports arrived in the 12 months to August 2026, up 205% from 749 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (63.6%), malfunction (35.8%) and death (0.6%); across all drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes reports (product code NVN) death is recorded in 2.2% and malfunction in 41.6%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are failure to capture (21%), high capture threshold (16.4%) and high impedance (15.7%). The patient problems coded most often are perforation, bradycardia and syncope/fainting. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 229,796 reports carrying product code NVN. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Failure to capture | 642 | 21% | 12.6% |
| High capture threshold | 502 | 16.4% | 10.7% |
| High impedance | 478 | 15.7% | 9.1% |
| Device dislodged or dislocated | 429 | 14.1% | 15.8% |
| Insufficient device problem information | 414 | 13.6% | 2.6% |
| Over-sensing | 318 | 10.4% | 17.9% |
| Signal artifact/noise | 314 | 10.3% | 9% |
| Defective devicethe device was defective | 244 | 8% | 1.7% |
| Fracturea broken bone | 192 | 6.3% | 4.7% |
| Under-sensing | 179 | 5.9% | 4.5% |
| Material integrity problema problem with the device material | 176 | 5.8% | 2.2% |
| Failure to read input signal | 118 | 3.9% | 0.6% |
| Pacing problem | 113 | 3.7% | 4.4% |
| Mechanical problema mechanical problem | 95 | 3.1% | 1.5% |
| Positioning problem | 90 | 2.9% | 1.6% |
| Low impedance | 72 | 2.4% | 5.1% |
| Device contamination with body fluid | 50 | 1.6% | 0.1% |
| Off-label use | 45 | 1.5% | 0.3% |
| Impedance problem | 32 | 1% | 2.2% |
| Device sensing problem | 22 | 0.7% | 3.7% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Perforation | 80 | 2.6% |
| Bradycardiaslow heart rate | 71 | 2.3% |
| Syncope/fainting | 51 | 1.7% |
| Device overstimulation of tissue | 41 | 1.3% |
| Discomfortdiscomfort | 41 | 1.3% |
| Dizzinesslight-headedness or unsteadiness | 38 | 1.2% |
| Painpain, site not specified | 38 | 1.2% |
| Asystole | 37 | 1.2% |
| Cardiac perforation | 33 | 1.1% |
| Pericardial effusionfluid around the heart | 33 | 1.1% |
| Twiddlers syndrome | 30 | 1% |
| Sepsisa severe body-wide response to infection | 28 | 0.9% |
| Chest painchest pain | 26 | 0.9% |
| Swelling/ edema | 26 | 0.9% |
| Erosion | 23 | 0.8% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Ingevity + | Product code NVN | All MAUDE reports |
|---|---|---|---|
| Reports | 3,053 | 229,796 | 26,136,888 |
| Share of that pool | — | 1.3% | 0% |
| Classified as death, per 1,000 reports | 6 | 22 | 9 |
| Classified as injury | 63.6% | 56.2% | 36.2% |
| Classified as malfunction | 35.8% | 41.6% | 62.3% |
| Filed by the manufacturer | 99.7% | 96.9% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code NVN
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Tendril Sts | 54,036 | 4,320 | 3.1% |
| SelectSecure MRI SureScan | 20,961 | 4,994 | 1.3% |
| Tendril St | 20,156 | 547 | 5.2% |
| Ingevity Mri | 17,101 | 1,749 | 0.3% |
| Ingevity+ | 15,340 | 2,150 | 0.3% |
| Tendril Sdx Lead | 9,380 | 431 | 4.5% |
| CapSure Fix MRI | 5,755 | 600 | 0.6% |
| Solia S 53 | 4,997 | 647 | 0.5% |
| Tendril Mri | 7,076 | 422 | 4.1% |
| Drug Eluting Permanent Right Ventricular Rv Or Right Atrial Ra Pacemaker Ele | 4,462 | 405 | 0.3% |
| Capsurefix Mri Surescan | 4,247 | 0 | 2.8% |
| Tendril Sdx | 8,316 | 3 | 2.3% |
| Ingevity | 9,039 | 299 | 0.9% |
| Dextrus 4136 | 5,698 | 0 | 0.8% |
| Isoflex Optim Lead | 7,889 | 437 | 2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Ingevity + reports
How many FDA reports name Ingevity +?
3,053 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 2,281 in the latest 12 months.
What kinds of events are reported?
injury (63.6%), malfunction (35.8%) and death (0.6%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
failure to capture (21%), high capture threshold (16.4%), high impedance (15.7%), device dislodged or dislocated (14.1%) and insufficient device problem information (13.6%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.7%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Ingevity + was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.